Navigation Links
Ikaria® to Present at 14th Annual BIO CEO & Investor Conference
Date:2/6/2012

HAMPTON, N.J., Feb. 6, 2012 /PRNewswire/ -- Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies designed to address the significant needs of critically ill patients in the hospital and ICU settings, today announced that its Chairman and CEO, Daniel Tasse, will present at the 14th Annual BIO CEO & Investor Conference.  Mr. Tasse's presentation will be given on Monday, February 13, 2012 at 3:30 p.m. EST in the Park South of the Waldorf Astoria in New York, NY.

About Ikaria, Inc.
Ikaria, Inc. is a critical care company focused on developing and commercializing innovative therapies designed to address the significant needs of critically ill patients. The company's lead product is INOMAX® (nitric oxide) for inhalation, the only FDA-approved drug for the treatment of hypoxic respiratory failure associated with pulmonary hypertension in term and near-term infants. It is offered through the INOMAX therapy package, an all-inclusive offering of drug product, drug-delivery system, on-site training and 24/7/365 technical assistance and support. The INOMAX therapy package also is marketed in Puerto Rico, Canada, Australia, Mexico and Japan. The company is investigating additional indications for INOMAX in bronchopulmonary dysplasia, and for inhaled nitric oxide with the INOpulse® DS drug-delivery system as a drug-device combination product in pulmonary arterial hypertension (PAH) and chronic obstructive pulmonary disease (COPD). Ikaria's late-stage pipeline is also comprised of LUCASSIN® (terlipressin), a potential treatment for Hepatorenal Syndrome Type 1; as well as Bioabsorbable Cardiac Matrix (BCM), a potential treatment for preventing cardiac remodeling and subsequent congestive heart failure following acute myocardial infarction. Ikaria is headquartered in Hampton, NJ, with a research facility in Madison, WI, and manufacturing facilities in Port Allen, LA and Madison, WI.  Please visit www.ikaria.com. Company Contact:Media Contacts:Samina Bari

Claire SojdaIkaria, Inc.

Tiberend Strategic Advisors, Inc.(908) 238-6372  

(212) 827-0020samina.bari@ikaria.comcsojda@tiberend.com 

 


'/>"/>
SOURCE Ikaria, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Ikaria® to Present at 2011 BIO Investor Forum
2. Ikaria® To Present at 2011 BIO Business Forum and International Convention
3. Cepheid to Webcast Upcoming Financial Presentations
4. Codexis to Present at the Pacific Crest and Jefferies Conferences
5. Life Technologies to Present at Upcoming Investment Conferences in February
6. MiMedx to Present at American Academy of Orthopaedic Surgeons Annual Meeting
7. Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims
8. BioRestorative Therapies to Present at 7th International Conference on Cell Therapy for Cardiovascular Disease
9. Genomic Health Presents Results From First Clinical Decision Making Study of Oncotype DX® Colon Cancer at the 2012 Gastrointestinal Cancers Symposium
10. LCA-Vision to Present at the Noble Financial Eighth Annual Equity Conference
11. PharmAthene to Present at the Noble Financial Eighth Annual Equity Conference on Tuesday, January 17, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... , ... June 21, 2016 , ... New light-based technologies ... into the tissue — promise to enable both compact, wearable devices for point-of-care diagnostics ... deeper under the skin. , Recent work and visionary future directions are detailed in ...
(Date:6/22/2016)... 22, 2016  Mesa Biotech Inc., a privately-held, ... platform designed specifically for point-of-care (POC) infectious disease ... advisory board (SAB). Approved by the executive leadership ... chartered to advise on the development and commercialization ... by Dr. Steve Young , this world-class ...
(Date:6/22/2016)... On Tuesday, June 21, 2016, the NASDAQ Composite ... Jones Industrial Average advanced 0.14% to finish at 17,829.73; and ... were broad based as five out of nine sectors ended ... following equities: Minerva Neurosciences Inc. (NASDAQ: NERV ), ... (NASDAQ: TRVN ), and Anthera Pharmaceuticals Inc. (NASDAQ: ...
(Date:6/21/2016)... ... 21, 2016 , ... Three young scientists are being recognized for discovering novel ... with today’s announcement of the winners of the 2016 Blavatnik National Awards for ... Foundation and administered by the New York Academy of Sciences , honor the ...
Breaking Biology Technology:
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... their customers enhanced security to access and transact ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
Breaking Biology News(10 mins):